Thank you, E. coli: Vancouver’s Absci uses bacteria to make ‘exciting’ drug discoveries
The primary thought that crossed Sean McClain's thoughts was one thing like, "We did it."
It was July twenty second on the Nasdaq headquarters in New York. McClain had gone out and in of conferences and interviews for hours,…